KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Current Taxes: 2023-2024

Historic Current Taxes for Xenon Pharmaceuticals (XENE) over the last 2 years, with Dec 2024 value amounting to $5.7 million.

  • Xenon Pharmaceuticals' Current Taxes was N/A to $231,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $231,000, marking a year-over-year change of. This contributed to the annual value of $5.7 million for FY2024, which is 1538.62% up from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Current Taxes of $5.7 million as of FY2024, which was up 1,538.62% from $347,000 recorded in FY2023.
  • Over the past 5 years, Xenon Pharmaceuticals' Current Taxes peaked at $5.7 million during FY2024, and registered a low of $347,000 during FY2023.
  • For the 2-year period, Xenon Pharmaceuticals' Current Taxes averaged around $3.0 million, with its median value being $3.0 million (2023).
  • Data for Xenon Pharmaceuticals' Current Taxes shows a peak YoY skyrocketed of 1,538.62% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Xenon Pharmaceuticals' Current Taxes stood at $347,000 in 2023, then skyrocketed by 1,538.62% to $5.7 million in 2024.